Clin2
NCT06940648Possibly a fitEnrolling by invitation

Bladder lesion removal with a new surgical tool

Bladder Neoplasm

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests a new tool to remove bladder lesions through the urethra. If you have a small bladder lesion that needs to be removed, this study may be an option.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
22 years and older
Study type
Interventional

Who can take part

  • You are 22 years or older.
  • You need to have a bladder lesion removed or biopsied.
  • The lesion is smaller than 3 cm (about 1.2 inches).
  • You can have general anesthesia.
  • You do not have a nickel allergy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06281080Recruiting
New robotic tool for removing early bladder tumors

This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.

Shatin
NCT07728071Not yet recruiting
Testing a new disposable tool for enlarged prostate surgery

This trial tests a new disposable tool for removing excess prostate tissue in men with an enlarged prostate (BPH). It aims to see if the tool makes surgery faster and more efficient while reducing symptoms.

Shatin
NCT06848868Recruiting· Phase 1
Clinic-based scope for bladder cancer follow-up

This trial tests if a procedure done in the clinic, without general anesthesia, can safely check the upper urinary tract after kidney-sparing surgery for urothelial cancer. It may reduce the need for hospital visits.

Hong Kong
NCT07724886Not yet recruiting
Bladder tumor removal plus BCG for intermediate- or high-risk cancer

This study tests a newer way to remove bladder tumors (called ERBT) combined with BCG, a standard immunotherapy placed in the bladder, for people with bladder cancer that is not too advanced. The goal is to see if this combination helps reduce the chance of the cancer coming back.

Hong Kong
NCT04235764Recruiting
Testing a new bladder-tumor surgery tool for removed tissue

This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.

Bethesda, Maryland
NCT06184516Recruiting· Phase 2
Bladder cancer study: testing a tool to see if womb and ovaries can be saved

This trial is testing a decision-making tool to help women with bladder cancer choose whether to keep their uterus, ovaries, and other pelvic organs during bladder removal surgery. It may help maintain quality of life after surgery.

Gainesville, Florida

Hear when a new Bladder Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.